Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsDrreddyslaboratories

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • NMDC positional buy, stay with Dr Reddy's Labs: Sukhani

      According to Sudarshan Sukhani of s2analytics.com, NMDC positional buy and feels that one can stay with Dr Reddy's Labs.

    • Buy Divi's Labs & Godrej Industries: Manoj Murlidharan

      In an interview to CNBC-TV18, Manoj Murlidharan of Religare Securities shared his readings and outlook on Futures and Options (F&O) side of the market, specific stocks and sectors.

    • Buy Sun Pharma; Ajanta Pharma better than Lupin: Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Sun Pharma and feels that Ajanta Pharma better than Lupin.

    • Competition bothering DRL, will shift to other stocks: Tulsian

      In an interview to CNBC-TV18, SP Tulsian of sptulsian.com shared his reading and outlook on the market as well as on various stocks and sectors.

    • Strongly bullish on Dr Reddy's Labs, target Rs 3405: Rajat Bose

      Rajat Bose of rajatkbose.com is Dr Reddy's Laboratories strongly bullish on Dr Reddy's Laboratories with a target of Rs 3405.

    • Dr Reddy's Labs will head to Rs 4500, says Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that Dr Reddy's Labs will eventually go to Rs 4,500.

    • Quick tips: How to trade 4 largecaps stocks post Q1 results

      Credit Suisse downgrades DRL to underperform from neutral as sharp erosion in the US business leads to high EPS cut. It has also slashed FY17/18 EPS by 35/19 percent and target to Rs 2750 per share. Near-term outlook weak with further hit from expiry of McNeil contract.

    • Buy Bajaj Finance, JSW Steel; short Dr Reddy's Labs: Ashish Kyal

      Ashish Kyal of wavesstrategy.com is of the view that one can buy Bajaj Finance and JSW Steel and short Dr Reddy's Labs.

    • Buy Ceat, Dr Reddy's, CONCOR, Vedanta: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Ceat, Dr Reddy's Labs, Container Corporation of India and Vedanta.

    • Optimistic on logistics; like Aurobindo & DRL: Mayuresh Joshi

      In an interview to CNBC-TV18 Mayuresh Joshi of Angel Broking shared his reading and outlook on the market as well as on various stocks and sectors.

    • Buy SBI, Hero Moto, Bajaj Auto, Maruti, Lupin: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying SBI, Hero Moto, Bajaj Auto, Maruti Suzuki and Lupin.

    • Buy Dr Reddy's Labs, Max Financial; sell Tata Steel: Gujral

      According to Ashwani Gujral of ashwanigujral.com, one can buy Dr Reddy's Laboratories and Max Financial and sell Tata Steel.

    • Buy Dr Reddy's Labs, Aurobindo Pharma, M&M: Sudarshan Sukhani

      According to Sudarshan Sukhani of s2analytics.com, one can buy Dr Reddy's Laboratories, Aurobindo Pharma and Mahindra & Mahindra.

    • Buy Pidilite Industries, Dr Reddy's Labs: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Pidilite Industries and Dr Reddy's Labs.

    • Prefer Sun Pharma, Dr Reddy's Lab: Sharmila Joshi

      Sharmila Joshi of sharmilajoshi.com is of the view that one may prefer Sun Pharmaceutical Industries and Dr Reddy's Laboratories.

    • Stock calls: Analysts tell you how to trade 7 key stocks today

      CLSA has retained underperform call on HUL with a target of Rs 885 per share as the company continues to see sluggish growth trend. Change over to IndAS impacted several line items in income statement.

    • Buy Dr Reddy's Labs, DHFL: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Dr Reddy's Labs and DHFL.

    • Tulsian upbeat on pharma, logistics cos; negative on telecom

      SP Tulsian, sptulsian.com in an interview to CNBC-TV18 while sharing his views why 8K Miles does not warrant a buy at current levels and why he is bullish on the pharma space.

    • Buy Sun Pharma, Lupin, Dr Reddy's Labs on declines: Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Sun Pharma, Lupin and Dr Reddy's Laboratories on declines.

    • Hold Asian Paints, buy Dr Reddy's; sell Just Dial: Sukhani

      Sudarshan Sukhani of s2analytics.com recommends holding Asian Paints and advises buying Dr Reddy's Labs and JSW Steel while one can sell Just Dial.

    • Buy Dr Reddy's Labs, Hindustan Unilever, HDFC: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Dr Reddy's Laboratories, Hindustan Unilever and HDFC.

    • Buy SRF; sell Bharti Infratel, Mindtree: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying SRF and sell Bharti Infratel and Mindtree.

    • Here are a few stocks ideas from Mayuresh Joshi

      In an interview to CNBC-TV18's Sonia Shenoy & Anuj Singhal, Mayuresh Joshi of Angel Broking shared his readings and outlook on specific stocks and sectors.

    • Here are Sanjiv Bhasin's top trading ideas

      In an interview to CNBC-TV18, Sanjiv Bhasin of IIFL shared his reading and outlook on the market.

    • Pharma space looks attractive: Parag Thakkar

      Parag Thakkar of HDFC Securities is of the view that pharma space looks attractive.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347